SKBA Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Hold
495,750
1.91% 21
2025
Q4
$12.3M Buy
495,750
+3,300
+0.7% +$83.2K 1.75% 29
2025
Q3
$12.5M Sell
492,450
-3,100
-0.6% -$76.5K 1.73% 28
2025
Q2
$12M Buy
495,550
+47,200
+11% +$1.1M 1.73% 28
2025
Q1
$11.4M Sell
448,350
-1,900
-0.4% -$49.7K 1.69% 23
2024
Q4
$11.9M Buy
450,250
+21,400
+5% +$580K 1.89% 20
2024
Q3
$12.4M Buy
428,850
+17,000
+4% +$496K 1.84% 20
2024
Q2
$11.5M Buy
411,850
+97,750
+31% +$2.69M 1.85% 24
2024
Q1
$8.72M Buy
314,100
+19,500
+7% +$541K 1.36% 39
2023
Q4
$8.48M Buy
+294,600
New +$8.91M 1.43% 40
2023
Q1
Sell
-7,000
Closed -$359K 78
2022
Q4
$359K Hold
7,000
0.07% 62
2022
Q3
$306K Sell
7,000
-3,450
-33% -$168K 0.06% 64
2022
Q2
$548K Hold
10,450
0.11% 55
2022
Q1
$541K Sell
10,450
-700
-6% -$36.3K 0.1% 56
2021
Q4
$658K Sell
11,150
-2,100
-16% -$104K 0.12% 53
2021
Q3
$570K Buy
13,250
+100
+0.8% +$4.43K 0.11% 57
2021
Q2
$515K Buy
13,150
+2,050
+18% +$79.7K 0.1% 58
2021
Q1
$402K Sell
11,100
-1,150
-9% -$40.8K 0.06% 64
2020
Q4
$451K Buy
12,250
+5,399
+79% +$198K 0.08% 58
2020
Q3
$239K Buy
+6,851
New +$240K 0.05% 67
2014
Q2
Sell
-472,347
Closed -$14.4M 96
2014
Q1
$14.4M Buy
472,347
+93,911
+25% +$2.8M 1.34% 38
2013
Q4
$11M Sell
378,436
-8,745
-2% -$255K 1.28% 38
2013
Q3
$10.6M Sell
387,181
-100,867
-21% -$2.74M 1.28% 41
2013
Q2
$13M Buy
+488,048
New +$13.5M 1.53% 31

Other funds holding PFE

SKBA Capital Management's PFE Position: Q1 2026 in Review

SKBA Capital Management held its Pfizer (PFE) position steady in Q1 2026 at 495,750 shares worth $13.9M. The position accounts for 1.91% of the portfolio, ranked #21.

SKBA Capital Management first reported a position in PFE in Q2 2013 and has held it in 24 quarters since. The position peaked at $14.4M in Q1 2014. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SKBA Capital Management held 495,750 shares of Pfizer worth $13.9M as of Q1 2026.
  • SKBA Capital Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 1.91% of SKBA Capital Management's portfolio in Q1 2026, its #21 holding.
  • SKBA Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 24 quarters since.
  • SKBA Capital Management's Pfizer position peaked at $14.4M in Q1 2014.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SKBA Capital Management's 13F filing for Q1 2026, filed 13 May 2026.